Chlamydia cannot cause HIV. They are two completely different infections caused by different pathogens. However, having an active chlamydia infection roughly doubles your risk of acquiring HIV if you’re exposed to it. This happens because chlamydia triggers changes in your body’s genital and rectal tissues that make it easier for HIV to gain a foothold.
How Chlamydia Makes HIV Transmission Easier
When chlamydia infects the cells lining your genital or rectal tract, your immune system sends infection-fighting cells to the area. Ironically, some of these cells are the exact ones HIV targets. This flood of immune cells to the infection site essentially rolls out a welcome mat for HIV, giving the virus more targets to latch onto right where sexual exposure happens.
Chlamydia also alters the local immune environment in ways that favor HIV. The infection triggers natural antimicrobial molecules called defensins, which under normal circumstances help fight off invaders. But certain defensins can actually promote HIV’s ability to infect cells. On top of that, chlamydia activates inflammatory pathways in the mucosal lining that further weaken the body’s first line of defense against HIV entry. The net effect is that tissues that would normally resist HIV become significantly more vulnerable.
The Numbers: How Much Does Chlamydia Raise HIV Risk?
The size of the risk increase depends on where the chlamydia infection is located. Rectal chlamydia carries the highest risk. Studies in men who have sex with men found that rectal chlamydia was associated with a 2.5-fold increase in new HIV diagnoses, even after adjusting for differences in sexual behavior. Data from the involveMENt trial, one of the more rigorous studies on this question, found a similar magnitude: about a 2.7-fold increase in HIV acquisition among people with rectal STIs.
Urethral chlamydia also raises HIV risk, though somewhat less. CDC modeling estimates place the increased risk of HIV acquisition at about 1.5 times the baseline for urethral infections, compared to roughly twice the baseline for rectal infections. These numbers may sound modest in isolation, but across a population where chlamydia is common, the cumulative effect on HIV transmission is substantial.
Chlamydia Also Increases HIV Spread From People Already Positive
The relationship works in both directions. For someone already living with HIV, a chlamydia co-infection increases the amount of virus present in genital fluids. A pooled analysis of three studies found that women with chlamydia were nearly twice as likely to be shedding HIV in their genital secretions compared to those without chlamydia. The largest study in that group, conducted among female sex workers, found chlamydia-positive women were three times more likely to be shedding detectable HIV.
This matters because higher viral concentrations in genital fluids translate directly to higher transmission risk for sexual partners. Even someone on HIV treatment who has well-controlled blood levels of the virus could potentially shed more virus locally during an active chlamydia infection.
Why Rectal Infections Carry Greater Risk
The rectal lining is thinner and more fragile than the lining of the cervix or urethra, which already makes it more susceptible to HIV. When chlamydia infects rectal tissue, it compounds this vulnerability by drawing large numbers of HIV-target immune cells into an area that’s already structurally easier for the virus to penetrate. The consistent finding across multiple studies is roughly a 2.5-fold increase in HIV risk with rectal chlamydia, a number that holds up even when researchers account for the fact that people with rectal STIs may also have more frequent unprotected anal sex.
Does Treating Chlamydia Lower HIV Risk?
Yes, though the effect at a population level is more gradual than you might expect. A CDC modeling study estimated that increasing annual chlamydia and gonorrhea screening among sexually active men who have sex with men by 60% could prevent about 4.7% of new HIV infections over a decade. When screening was focused on people with multiple recent partners, the effect nearly doubled to 9.8% of HIV infections averted over the same period.
These numbers sound small in percentage terms, but they represent real infections prevented. The study’s authors described the reductions as “modest but clinically relevant.” Part of the reason the effect isn’t larger is that chlamydia is only one of many factors driving HIV transmission. But the takeaway is clear: finding and treating chlamydia promptly removes one of the conditions that makes HIV transmission more likely. Since chlamydia is curable with a short course of antibiotics, it’s one of the more straightforward risk factors to eliminate.
What This Means in Practice
If you have chlamydia, you don’t have HIV, and chlamydia will never turn into HIV on its own. But an active chlamydia infection creates a window of increased vulnerability. During that window, an encounter that might not have resulted in HIV transmission could tip in the wrong direction. The practical implications are straightforward: regular STI screening catches chlamydia early (it’s often symptomless), prompt treatment closes the vulnerability window, and using condoms or PrEP provides an additional layer of protection against HIV during any period of increased risk.
People at highest risk of both infections benefit most from frequent screening. Current guidelines generally recommend screening every 3 to 6 months for sexually active men who have sex with men and annual screening for sexually active women under 25. Since chlamydia rarely causes symptoms, especially rectal chlamydia, you can’t rely on feeling sick to know you have it.